RSS Feeds
Search

Out-licensing

Up-to-date access to technology licensing opportunities worldwide.

Licensing opportunities

No results found for given criteria.

Related Reports

Market Research Reports provided by reports.iptechex.com
Osteosarcoma Therapeutics - Pipeline Assessment and Market Forecasts to 2017
Jun 2011 - 82 pages - $2,000
Osteosarcoma Global Clinical Trials Review, Q4, 2010
Dec 2010 - 56 pages - $1,000
FDA Approval for Xgeva (denosumab): Novel Therapies to Drive the Bone Metastases Therapy Market
Dec 2010 - 5 pages - $500
Supportive Care in Oncology Market Forecast
Nov 2009 - $15,200
Osteosarcoma - Pipeline Review, Q4 2010
Dec 2010 - 35 pages - $500
US Oncology, Inc. - SWOT Analysis
Nov 2010 - 26 pages - $125
Osteosarcoma - Pipeline Review, H2 2011
Aug 2011 - 97 pages - $500
Bone Cancer Global Clinical Trials Review, Q4, 2010
Oct 2010 - 43 pages - $1,000
US Oncology, Inc.: SWOT Analysis & Company Profile
Dec 2010 - 19 pages - $99
Osteosarcoma - Pipeline Review, Q2 2011
Apr 2011 - 96 pages - $500
More Related Market Research Reports >>>

Your selection

Industry sector
Biotechnology del
Research supplies del
Therapeutic target
Oncology del
Bone cancer del
Osteosarcoma del

Browse By

Development phase
Early Stage
Preclinical
Phase I
Phase I/II
Phase II
Phase III
Phase III/IV
Preregistration
Registered

Clients in focus...

Get the Flash Player to see this rotator.

© Copyright 1998-2013 IP Technology Exchange, Inc All rights reserved. Terms and Conditions | Contact us